Axon Enterprise, Inc (NASDAQ:AXON) Shares Purchased by Asset Management One Co. Ltd.

Asset Management One Co. Ltd. lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 9.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 30,285 shares of the biotechnology company's stock after acquiring an additional 2,707 shares during the period. Asset Management One Co. Ltd.'s holdings in Axon Enterprise were worth $15,928,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Chapin Davis Inc. purchased a new position in shares of Axon Enterprise during the 1st quarter worth $324,000. Oppenheimer Asset Management Inc. raised its holdings in shares of Axon Enterprise by 618.4% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 5,589 shares of the biotechnology company's stock worth $2,940,000 after acquiring an additional 4,811 shares during the period. XML Financial LLC purchased a new position in shares of Axon Enterprise during the 1st quarter worth $229,000. Pursue Wealth Partners LLC purchased a new stake in Axon Enterprise in the 1st quarter valued at about $5,019,000. Finally, Flagship Harbor Advisors LLC raised its holdings in Axon Enterprise by 2.0% in the 1st quarter. Flagship Harbor Advisors LLC now owns 1,863 shares of the biotechnology company's stock valued at $980,000 after buying an additional 37 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Up 1.8%

AXON traded up $14.65 on Friday, reaching $818.60. The company's stock had a trading volume of 1,010,596 shares, compared to its average volume of 712,938. The company has a market capitalization of $63.73 billion, a price-to-earnings ratio of 197.73, a P/E/G ratio of 90.37 and a beta of 1.29. Axon Enterprise, Inc has a fifty-two week low of $279.02 and a fifty-two week high of $820.83. The stock has a 50 day moving average of $709.79 and a two-hundred day moving average of $629.30. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The company's revenue was up 31.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.15 earnings per share. As a group, analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Brittany Bagley sold 3,400 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the completion of the sale, the chief financial officer now directly owns 131,833 shares of the company's stock, valued at $92,283,100. This trade represents a 2.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Jennifer H. Mak sold 75 shares of the stock in a transaction on Friday, June 13th. The stock was sold at an average price of $771.81, for a total value of $57,885.75. Following the sale, the chief accounting officer now directly owns 15,240 shares of the company's stock, valued at approximately $11,762,384.40. This represents a 0.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock valued at $30,500,428 over the last three months. 4.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Bank of America boosted their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Finally, Barclays boosted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. One analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $699.55.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.